These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity. Mwakingwe-Omari A; Healy SA; Lane J; Cook DM; Kalhori S; Wyatt C; Kolluri A; Marte-Salcedo O; Imeru A; Nason M; Ding LK; Decederfelt H; Duan J; Neal J; Raiten J; Lee G; Hume JCC; Jeon JE; Ikpeama I; Kc N; Chakravarty S; Murshedkar T; Church LWP; Manoj A; Gunasekera A; Anderson C; Murphy SC; March S; Bhatia SN; James ER; Billingsley PF; Sim BKL; Richie TL; Zaidi I; Hoffman SL; Duffy PE Nature; 2021 Jul; 595(7866):289-294. PubMed ID: 34194041 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial. Sissoko MS; Healy SA; Katile A; Zaidi I; Hu Z; Kamate B; Samake Y; Sissoko K; Mwakingwe-Omari A; Lane J; Imeru A; Mohan R; Thera I; Guindo CO; Dolo A; Niare K; Koïta F; Niangaly A; Rausch KM; Zeguime A; Guindo MA; Bah A; Abebe Y; James ER; Manoj A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Doumbo O; Duffy PE Lancet Infect Dis; 2022 Mar; 22(3):377-389. PubMed ID: 34801112 [TBL] [Abstract][Full Text] [Related]
7. Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines. Stanisic DI; Liu XQ; De SL; Batzloff MR; Forbes T; Davis CB; Sekuloski S; Chavchich M; Chung W; Trenholme K; McCarthy JS; Li T; Sim BK; Hoffman SL; Good MF Malar J; 2015 Apr; 14():143. PubMed ID: 25890156 [TBL] [Abstract][Full Text] [Related]
8. A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults. Sklar MJ; Maiolatesi S; Patterson N; Sedegah M; Limbach K; Teneza-Mora N; Chuang I; Hollis-Perry KM; Banania JG; Guzman I; Ganeshan H; Reyes S; Hollingdale MR; Wong M; Lindstrom A; Reyes A; Alcorta Y; Garver L; Bankard K; Belmonte A; Belmonte M; Huang J; Gowda K; Inoue S; Velasco R; Bergmann-Leitner E; Hutter J; Lee T; Adams N; Chaudhury S; Hunt D; Tamminga C; Berrie E; Bellamy D; Bittaye M; Ewer K; Diggs C; Soisson LA; Lawrie A; Hill A; Richie TL; Villasante E; Epstein JE; Duplessis CA PLoS One; 2021; 16(9):e0256980. PubMed ID: 34495988 [TBL] [Abstract][Full Text] [Related]
9. Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers. Tumbo AM; Schindler T; Dangy JP; Orlova-Fink N; Bieri JR; Mpina M; Milando FA; Juma O; Hamad A; Nyakarungu E; Chemba M; Mtoro A; Ramadhan K; Olotu A; Makweba D; Mgaya S; Stuart K; Perreau M; Stapleton JT; Jongo S; Hoffman SL; Tanner M; Abdulla S; Daubenberger C Virol J; 2021 Jan; 18(1):28. PubMed ID: 33499880 [TBL] [Abstract][Full Text] [Related]
10. Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites. Schats R; Bijker EM; van Gemert GJ; Graumans W; van de Vegte-Bolmer M; van Lieshout L; Haks MC; Hermsen CC; Scholzen A; Visser LG; Sauerwein RW PLoS One; 2015; 10(5):e0124243. PubMed ID: 25933168 [TBL] [Abstract][Full Text] [Related]